Contaminated Heparin-Affected Patient Plasmas Are Associated With Activated Contact Systems

Kishimoto TK , Viswanathan K. , Ganguly T. , et al. Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med. 2008;358(23):2457-2467.

Fareed J. , Ahluwalia M. , Wahi R. , Ramaccioti E. , Hoppensteadt D. , Bick RL Contaminants in heparins continue to be unfolded. Int Angiol . 2008;27(6): 457-461.

Usdin S. The heparin story: analytics behind the times BioCentury. The Bernstein Report. February 23, 2009.

Hovingh P. , Piepkorn M. , Linker A. Biological implications of the structural, antithrombin affinity and anticoagulant activity relationships among vertebrate heparins and heparan sulphates. Biochem J. 1986;237(2):573-581.

Blossom DB , Kallen AJ , Patel PR , et al. Outbreak of adverse reactions associated with contaminated heparin . N Engl J Med. 2008;359(25):2674-2684.

FDA Information on Adverse Event Reports and Heparin: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm112669.htm (Accessed on April 30, 2010).

Guerrini M. , Beccati D. , Shriver Z. , et al. Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. Nat Biotechnol. 2008;26(6):669-675.

Guerrini M. , Zhang Z. , Shriver Z. , et al. Orthogonal analytical approaches to detect potential contaminants in heparin. Proc Natl Acad Sci U S A. 2009 ;106(40): 16956-16961.

Pan J. , Qian Y. , Zhou X. , et al. Oversulfated Chondroitin Sulfate is not the Sole Contaminant in Heparin. Nature Biotech 2010; 28:203-207.

Pan J. , Qian Y. , Zhou X. , et al. Identification of chemically sulfated/desulfated glycosaminoglycans in contaminated heparins and development of a simple assay for the detection of most contaminants in heparin. Glycobiology Insight. 2010;2:1-12.

Pan J. , Qi Y. , Zhou X. , Lu H. , Ramacciotti E. , Zhang L. Chemically Oversulfated Glycosaminoglycans are Potent Modulators of Contact System Activation and Different Cell Signaling Pathways. J Biol Chem 2010; doi:10.1074/jbc.M109.063735.

Akilesh S. , Jendrisak M. , Zhang L. , Lewis JS Jr , Liapis H. Acute renal allograft thrombosis in ‘seronegative’ anti-phospholipid syndrome. NDT Plus. 2008;2(2):181-182, sfn193.

Nosé Y. Hemodialysis patients’ deaths in the USA by contaminant suspected heparin originating from China. Artif Organs. 2008;32(6):425-426.

Greinacher A. , Warkentin TE Contaminated heparin. N Engl J Med. 2008;359(12):1291-1292; author reply 1293.

Fareed J. , Hoppensteadt DA , Fareed D. , et al. Survival of heparins, oral anticoagulants, and aspirin after the year 2010. Semin Thromb Hemost. 2008;34(4):411.

Saito A. , Munakata H. Analysis of plasma proteins that bind to glycosaminoglycans. Biochim Biophys Acta. 2007;1770(2):241-246.

Lindahl U. What else can ‘Heparin’ do? Haemostasis . 1999;29(suppl S1):38-47.

FDA report on 93 contaminated heparin associated deaths. http://articles.chicagotribune.com/2008-07-30/business/0807290482_1_oversulfated-chondroitin-sulfate-heparin-products-baxter-spokeswoman-erin-gardiner (Accessed on April 30, 2010).

Adiguzel C. , Bansal V. , Litinas E. , et al. Increased prevalence of antiheparin platelet factor 4 antibodies in patients may be due to contaminated heparin . Clin Appl Thromb Hemost. ; 2009 15(2):145-151.